BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
29 hedge funds and large institutions have $3.76M invested in Bellicum Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$390K | |
| 2 | +$92.6K | |
| 3 | +$43.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.2K |
| 5 |
LPL Financial
San Diego,
California
|
+$18.4K |
Top Sellers
| 1 | -$106K | |
| 2 | -$32K | |
| 3 | -$7K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$684 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$26 |